{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10145",
      "entity_text" : "IL-8",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:3488",
      "entity_text" : "glibenclamide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "When using PMNs from diabetic subjects, glibenclamide reduced IL-8 production upon B. pseudomallei infection or PMA activation, but not following LPS activation (XREF_FIG).",
  "reading_complete" : "2020-07-28T08:26:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T08:25:07Z",
  "trigger" : "reduced",
  "evidence" : [ "glibenclamide reduced IL-8" ],
  "pmc_id" : "3842541",
  "score" : 0
}